Mer kinase inhibitors (AstraZeneca/X-Chem)

N/A

Report date: 2025/03/20 15:23:06
NME

Base Information

Drug NameMer kinase inhibitors (AstraZeneca/X-Chem)
Drug Alias NameMer kinase checkpoint inhibitor (AstraZeneca/X-Chem)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase Mer inhibitors
TargetsTyrosine-protein kinase Mer
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesX-Chem IncAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A